Table 4.

Median Survival Time and HR for Patients with Various Genotypes

Polymorphism	Genotypes	Survival time (months)		Hazard ratio (HR)
		Mean (95% CI)	p value	HR (95% CI)	p value
TS 5ꞌ UTR VNTR	2R2R	23.44 (13.84-33.04)	0.003	1 (reference group)
	2R3R	39.36 (32.62-46.1)		0.47 (0.25-0.87)	0.02
	3R3R	47.17 (37.3-57.04)		0.24 (0.09-0.64)	0.005
TS 5ꞌ UTR SNP	3RC3RG	32 (4.28-59.72)	0.92	1 (reference group)
	2R3RG, 3RG3RG	47.84 (38.52-57.15)		0.51 (0.07-4.18)	0.53
	2R3RC, 3RC3RC	38.88 (31.82-45.94)		0.82 (0.11-6.1)	0.85
TS 3ꞌ UTR	del6/del6	31.67 (23.13-40.2)	0.84	1 (reference group)
	del6/ins6	37.22 (31.57-42.86)		1.64 (0.22-11.9)	0.63
	Ins6/ins6	33.22 (19.93-45.51)		1.82 (0.23-14.62)	0.57
ENOSF1 (rs2612091)	AA	30.71 (21.37-40.4)	0.17	1 (reference group)
	AG	36.39 (28.97-43.8)		0.73 (0.39-1.37)	0.32
	GG	45.8 (36.17-55.44)		0.47 (0.2-1.08)	0.08
ENOSF1 (rs2741171)	AA	36.84 (24.62-49.07)	0.97	1 (reference group)
	AG	37.41 (28.93-45.88)		0.92 (0.39-2.16)	0.85
	GG	36.79 (29.31-44.28)		1 (0.45-2.23)	0.99